Novel 1,4-dihydropyridine calcium antagonists. II. Synthesis and antihypertensive activity of 3-(4-(substituted amino)phenylalkyl)ester derivatives.
作者:Atsuyuki ASHIMORI、Taizo ONO、Yoshihisa INOUE、Satoshi MORIMOTO、Masahiro EDA、Takeshi UCHIDA、Yutaka OHTAKI、Yoshiyuki FUJINO、Hideaki KIDO、Yasushi OGURA、Chikara FUKAYA、Masahiro WATANABE、Kazumasa YOKOYAMA
DOI:10.1248/cpb.39.91
日期:——
distinctive. 2-[4-(4-Benzhydryl-1-piperazinyl)phenyl]ethyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate (4e), its 4-(4-cyano-2-pyridyl) analogue (4f), its 3-[4-(4-benzhydryl-1-piperazinyl)phenyl]propyl ester analogue (4h), its 2-[4-(4-benzhydryl-1-piperidinyl)phenyl]ethyl ester analogue (4j), and its 2-[4-(1-benzhydryl-4-piperidinyl)phenyl]ethyl ester analogue (4k) were selected
制备带有3- [4-(取代的氨基)苯基烷基]酯侧链的新型1,4-二氢吡啶衍生物,并测试其在自发性高血压大鼠中的抗高血压活性。与尼卡地平相比,大多数化合物显示出更有效的降压作用和更长的作用持续时间。具有二苯甲基哌嗪基和二苯甲基哌啶基的衍生物是独特的。2- [4-(4-苯甲基-1-哌嗪基)苯基]乙基1,4-二氢-2,6-二甲基-4-(3-硝基苯基)-3,5-吡啶二甲酸(4e),其4- (4-氰基-2-吡啶基)类似物(4f),其3- [4-(4-苯甲酰基-1-哌嗪基)苯基]丙基酯类似物(4h),其2- [4-(4-苯甲酰基-1) -哌啶基)苯基]乙酯类似物(4j),